NASDAQ POSITIONED AS A LEADER IN GARTNER’S 2016 MAGIC QUADRANT FOR OPERATIONAL RISK MANAGEMENT SOLUTIONS FOR ITS BWISE GRC PLATFORM
New York, December 23, 2016 – Nasdaq (Nasdaq: NDAQ) has been positioned in the Leaders Quadrant in Gartner’s 2016 Magic Quadrant for Operational Risk Management Solutions for BWise, its leading Governance, Risk Management and Compliance (GRC) software.
The annual report analyzed the ‘completeness of vision’ and ‘ability to execute’ of fourteen vendors in this space from around the globe. Gartner’s Magic Quadrant report states, “By providing a better understanding of these risks to business objectives, ORM enables better business performance and capital allocation. ORM solutions also help companies address the increasing pressure from regulators to improve the risk reporting in annual reports, and to improve the board of directors' role in enterprisewide ORM oversight.”
“We are pleased to have been recognized by Gartner as a leader in operational risk management,” said Jonathan Deeks, Head of Nasdaq BWise. “Businesses are operating in increasingly complex and regulated environments and operational risk management is a top priority for senior executives. We believe this recognition is due to Nasdaq BWise’s strengths gained from its heritage in financial services, as well as the strong growth achieved following investment in risk mitigation best practices and delivery models. We look forward to continuing to advancing our risk management solutions through leveraging our expertise and leadership in this space.”
Gartner, Magic Quadrant for Operational Risk Management Solutions, John A. Wheeler, Jie Zhang, December 13, 2016.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.